- Home
- GPRE vs ESPR Comparison
GPRE vs ESPR Comparison
Compare GPRE & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- ESPR
- Stock Information
- Founded
- GPRE 2004
- ESPR 2008
- Country
- GPRE United States
- ESPR United States
- Employees
- GPRE N/A
- ESPR N/A
- Industry
- GPRE Major Chemicals
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- ESPR Health Care
- Exchange
- GPRE Nasdaq
- ESPR Nasdaq
- Market Cap
- GPRE 631.4M
- ESPR 534.3M
- IPO Year
- GPRE N/A
- ESPR 2013
- Fundamental
- Price
- GPRE $11.17
- ESPR $2.75
- Analyst Decision
- GPRE Hold
- ESPR Buy
- Analyst Count
- GPRE 7
- ESPR 6
- Target Price
- GPRE $8.50
- ESPR $6.50
- AVG Volume (30 Days)
- GPRE 2.0M
- ESPR 8.5M
- Earning Date
- GPRE 11-11-2025
- ESPR 11-06-2025
- Dividend Yield
- GPRE N/A
- ESPR N/A
- EPS Growth
- GPRE N/A
- ESPR N/A
- EPS
- GPRE N/A
- ESPR N/A
- Revenue
- GPRE $2,397,101,000.00
- ESPR $268,125,000.00
- Revenue This Year
- GPRE N/A
- ESPR $13.05
- Revenue Next Year
- GPRE N/A
- ESPR N/A
- P/E Ratio
- GPRE N/A
- ESPR N/A
- Revenue Growth
- GPRE N/A
- ESPR N/A
- 52 Week Low
- GPRE $3.14
- ESPR $0.69
- 52 Week High
- GPRE $14.04
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- GPRE 59.41
- ESPR 56.28
- Support Level
- GPRE $8.93
- ESPR $2.52
- Resistance Level
- GPRE $12.31
- ESPR $2.76
- Average True Range (ATR)
- GPRE 0.66
- ESPR 0.20
- MACD
- GPRE 0.20
- ESPR -0.03
- Stochastic Oscillator
- GPRE 68.13
- ESPR 41.44
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.